TRLV Stock: Price, Earnings History and SEC Filings
Trulieve Cannabis Corp. (TRLV) last traded at $10.28, down 3.02% on the latest session and down 5.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.11 against an analyst estimate of $0.06, a beat of 83.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TRLV earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 7, 2026 | $0.11 | $0.06 | +83.33% |
TRLV beat the analyst EPS estimate in 1 of its last 1 reported quarters. Source: Nasdaq.
How TRLV reacts to earnings
Across its last 8 earnings releases, TRLV moved 5.3% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-05-07 | Before open | -4.90% |
| 2026-02-26 | Before open | +1.56% |
| 2025-11-05 | Before open | +2.27% |
| 2025-08-06 | Before open | -4.86% |
| 2025-05-07 | Before open | -2.46% |
| 2025-02-27 | Before open | +5.52% |
| 2024-11-05 | Before open | -8.27% |
| 2024-08-06 | Before open | +12.49% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
TRLV financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $1.2B | – | $229M | – | $-0.58 |
| 2024 | $1.2B | – | $149M | – | $-0.79 |
| 2023 | $1.1B | – | $162M | – | $-2.28 |
| 2022 | $1.2B | -$253M | -$142M | -20.7% | $-0.95 |
| 2021 | $932M | $17M | -$263M | 1.9% | $0.21 |
| 2020 | $522M | $63M | -$298000 | 12.1% | $0.53 |
| 2019 | $253M | $53M | -$53M | 21.0% | $0.46 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for TRLV
- 8-K · Aug 11, 2026Material agreement, Unregistered share sale, Bylaw change
- 10-Q · Aug 7, 2026
- 8-K · Aug 7, 2026Acquisition or disposal completed, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 5, 2026Shareholder vote, Financial statements and exhibits
- 8-K · Jul 2, 2026Officer or director change, Financial statements and exhibits
- DEF 14A · Jun 25, 2026
- 8-K · Jun 12, 2026Officer or director change, Financial statements and exhibits
- 8-K · Jun 11, 2026Shareholder vote, Financial statements and exhibits
- 8-K · Jun 9, 2026Other events, Financial statements and exhibits
- 8-K · Jun 4, 2026Material agreement, Acquisition or disposal completed, Financial statements and exhibits
Insider filing activity
TRLV insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
TRLV news
No recent headlines found. The live terminal has the full news feed.
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. (TRLV) is a US-listed public company on NYSE. The SEC classifies its business as Medicinal Chemicals & Botanical Products. It is incorporated in British Columbia Canada. Its fiscal year ends in December.